ARS Pharmaceuticals, Inc.

US$2.79As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SPRYHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR (18.41%)
Div yield —
ROE (294.57%)
Biotechnology
Beta (5Y) 1.16
PE TTM —
TSR TTM (68.86%)
Mkt cap US$280.5M
ROIC (173.90%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.31
18.60%
(57.87%)
Hold 8|7|9|10|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.06
0.06
0.06
0.07
21.66%
10.16%
7.68%
15.37%
Revenue$M
15.20
16.05
16.71
17.67
(0.48%)
6.82%
11.03%
16.26%
Peers (US$280.5M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.117
0.153
0.145
EBIT/Intx
3.042
0.046
0.052
Own earn%
5.33
60.90
48.77
Sh yield%
29.66
33.35
34.43
Owners
Insiders/Inst%
12.59
53.76
Short interest%
3.41
SBC / revenue%
1.17
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
19–25
$1 testx
—
Incr. ROIC%
0